Literature DB >> 24035445

Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels.

Gaspard d'Assignies1, Ghislaine Fontés, Claude Kauffmann, Martin Latour, Louis Gaboury, Yvan Boulanger, Bernard E Van Beers, Gilles Soulez, Vincent Poitout, An Tang.   

Abstract

OBJECTIVE: Magnetic resonance (MR) techniques allow noninvasive fat quantification. We aimed to investigate the accuracy of MR imaging (MRI), MR spectroscopy (MRS) and histological techniques to detect early-onset liver steatosis in three rat phenotypes assigned to an experimental glucolipotoxic model or a control group.
MATERIALS AND METHODS: This study was approved by the institutional committee for the protection of animals. Thirty-two rats (13 young Wistar, 6 old Wistar and 13 diabetic Goto-Kakizaki rats) fed a standard diet were assigned to a 72h intravenous infusion of glucose and Intralipid fat emulsion or a saline infusion. Plasma insulin levels were measured. Steatosis was quantified in ex vivo livers with gradient-recalled multi-echo MRI, MRS and histology as fat fractions (FF).
RESULTS: A significant correlation was found between multi-echo MRI-FF and MRS-FF (r=0.81, p<0.01) and a weaker correlation was found between histology and MRS-FF (r=0.60, p<0.01). MRS and MRI accurately distinguished young Wistar and Goto-Kakizaki rats receiving the glucose+Intralipid infusion from those receiving the saline control whereas histology did not. Significant correlations were found between MRI or MRS and insulin plasma level (r=0.63, p<0.01; r=0.57, p<0.01), and between MRI or MRS and C-peptide concentration (r=0.54, p<0.01; r=0.44, p<0.02).
CONCLUSIONS: Multi-echo MRI and MRS may be more sensitive to measure early-onset liver steatosis than histology in an experimental glucolipotoxic rat model.
© 2013.

Entities:  

Keywords:  Diabetes mellitus; FF; Fat fraction; GLU+IL; Glucose+Intralipid; Hepatic steatosis; IP; In-phase; Insulin; MR; MRI; MRS; Magnetic resonance; Magnetic resonance imaging; Magnetic resonance spectroscopy; NAFLD; NASH; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; OP; Opposed-phase; ROC; Receiver operating characteristic; SAL; Saline

Mesh:

Substances:

Year:  2013        PMID: 24035445      PMCID: PMC3914148          DOI: 10.1016/j.metabol.2013.08.003

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  42 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

3.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

Review 4.  Diagnosis of fatty liver disease: is biopsy necessary?

Authors:  Diamond Joy; Vallipuram R Thava; Brian B Scott
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-05       Impact factor: 2.566

5.  Metformin reverses fatty liver disease in obese, leptin-deficient mice.

Authors:  H Z Lin; S Q Yang; C Chuckaree; F Kuhajda; G Ronnet; A M Diehl
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

6.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

Authors:  Anneli Seppälä-Lindroos; Satu Vehkavaara; Anna-Maija Häkkinen; Takashi Goto; Jukka Westerbacka; Anssi Sovijärvi; Juha Halavaara; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

7.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Thomas Tran; James E Everhart
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

8.  Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling.

Authors:  Scott B Reeder; Philip M Robson; Huanzhou Yu; Ann Shimakawa; Catherine D G Hines; Charles A McKenzie; Jean H Brittain
Journal:  J Magn Reson Imaging       Date:  2009-06       Impact factor: 4.813

9.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

Review 10.  Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?

Authors:  E Bugianesi; C Zannoni; E Vanni; R Marzocchi; G Marchesini
Journal:  Dig Liver Dis       Date:  2004-03       Impact factor: 4.088

View more
  4 in total

1.  New research developments and insights from Metabolism.

Authors:  Olivia M Farr; Michelle Camp; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-12-17       Impact factor: 8.694

Review 2.  Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Gregory Thomas Brown; David E Kleiner
Journal:  Metabolism       Date:  2015-12-02       Impact factor: 8.694

Review 3.  Trends in the management and burden of alcoholic liver disease.

Authors:  Philippe Mathurin; Ramon Bataller
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 4.  Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.

Authors:  Felix Stickel; Christian Datz; Jochen Hampe; Ramon Bataller
Journal:  Gut Liver       Date:  2017-03-15       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.